Silexion Therapeutics Ltd. (SLXN) Insider Trading Activity

NASDAQ$0.1555
Market Cap
$64,232.00
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
773 of 849
Rank in Industry
445 of 491

SLXN Insider Trading Activity

SLXN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$31,032
1
100

Related Transactions

Shirvan MitchellCSO and CDO
0
$0
1
$31,032
$-31,032

About Silexion Therapeutics Ltd.

Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, …

Insider Activity of Silexion Therapeutics Ltd.

Over the last 12 months, insiders at Silexion Therapeutics Ltd. have bought $0 and sold $31,032 worth of Silexion Therapeutics Ltd. stock.

On average, over the past 5 years, insiders at Silexion Therapeutics Ltd. have bought $0 and sold $31,032 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Silexion Therapeutics Ltd.

2026-03-26SaleShirvan MitchellCSO and CDO
22,818
4.2229%
$1.36
$31,032
-80.69%
Total: 1
*Gray background shows transactions not older than one year

SLXN Institutional Investors: Active Positions

Increased Positions3+60%13,230+52.74%
Decreased Positions<1-20%20,000-79.73%
New Positions2New12,231New
Sold Out Positions<1Sold Out20,000Sold Out
Total Postitions7+40%18,315-26.99%

SLXN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Montag A & Associates Inc$6.000.1%3,000+3,000New2025-09-30
Sbi Securities Co., Ltd.$2.000.04%1,060-15,354-93.54%2025-09-30
Ubs Group Ag$1.000.02%692-6,592-90.5%2025-09-30
Pflug Koory, Llc$1.000.01%333+333New2025-09-30
Stonex Group Inc.$00%0-749Sold Out2025-09-30
Meyer Handelman Co$00%0-2,198Sold Out2025-09-30
Virtu Financial Llc$00%0-951Sold Out2025-09-30
Bank Of America Corp /De/$00%0-33Sold Out2025-09-30
Wildcat Capital Management, Llc$00%0-7,562Sold Out2025-09-30
Moloney Securities Asset Management, Llc$00%0-20,000Sold Out2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.